161 related articles for article (PubMed ID: 32985591)
1. Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells.
Romero-García R; Gómez-Jaramillo L; Mateos RM; Jiménez-Gómez G; Pedreño-Horrillo N; Foncubierta E; Rodríguez-Gutiérrez JF; Garzón S; Mora-López F; Rodríguez C; Valor LM; Campos-Caro A
Sci Rep; 2020 Sep; 10(1):15899. PubMed ID: 32985591
[TBL] [Abstract][Full Text] [Related]
2. Methylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma.
Zhang YW; Zhang J; Li J; Zhu JF; Yang YL; Zhou LL; Hu ZL; Zhang F
Leuk Lymphoma; 2015; 56(8):2429-38. PubMed ID: 25487076
[TBL] [Abstract][Full Text] [Related]
3. Loss of promoter methylation contributes to the expression of functionally impaired PRDM1β isoform in diffuse large B-cell lymphoma.
Zhang YW; Xie HQ; Chen Y; Jiao B; Shen ZX; Chen SJ; Zhao WL
Int J Hematol; 2010 Oct; 92(3):439-44. PubMed ID: 20859709
[TBL] [Abstract][Full Text] [Related]
4. PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor.
Zhao WL; Liu YY; Zhang QL; Wang L; Leboeuf C; Zhang YW; Ma J; Garcia JF; Song YP; Li JM; Shen ZX; Chen Z; Janin A; Chen SJ
Blood; 2008 Apr; 111(7):3867-71. PubMed ID: 18235046
[TBL] [Abstract][Full Text] [Related]
5. Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma.
Liu YY; Leboeuf C; Shi JY; Li JM; Wang L; Shen Y; Garcia JF; Shen ZX; Chen Z; Janin A; Chen SJ; Zhao WL
Blood; 2007 Jul; 110(1):339-44. PubMed ID: 17379744
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.
Nie K; Zhang T; Allawi H; Gomez M; Liu Y; Chadburn A; Wang YL; Knowles DM; Tam W
Am J Pathol; 2010 Sep; 177(3):1470-9. PubMed ID: 20651244
[TBL] [Abstract][Full Text] [Related]
7. [Effect of low-dose 2-methoxyestradiol on the expressions of two isoforms of PRDM1 gene in myeloma].
Jiang H; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):38-41. PubMed ID: 19563034
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation.
Zhang Z; Liang L; Li D; Nong L; Liu J; Qu L; Zheng Y; Zhang B; Li T
Hematol Oncol; 2017 Dec; 35(4):645-654. PubMed ID: 27704586
[TBL] [Abstract][Full Text] [Related]
9. PRDM1 is a tumor suppressor gene in natural killer cell malignancies.
Küçük C; Iqbal J; Hu X; Gaulard P; De Leval L; Srivastava G; Au WY; McKeithan TW; Chan WC
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20119-24. PubMed ID: 22143801
[TBL] [Abstract][Full Text] [Related]
10. PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoids.
Liu C; Banister CE; Weige CC; Altomare D; Richardson JH; Contreras CM; Buckhaults PJ
Proc Natl Acad Sci U S A; 2018 May; 115(22):E5066-E5075. PubMed ID: 29760071
[TBL] [Abstract][Full Text] [Related]
11. FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma.
Vogel MJ; Xie L; Guan H; Tooze RM; Maier T; Kostezka U; Maier HJ; Holzmann K; Chan FC; Steidl C; Reichel JB; Weitzer CD; Gehringer F; Kick AB; Cesarman E; Roshal M; Gascoyne RD; Möller P; Wirth T; Ushmorov A
Blood; 2014 Nov; 124(20):3118-29. PubMed ID: 25232062
[TBL] [Abstract][Full Text] [Related]
12. Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers.
Agirre X; Castellano G; Pascual M; Heath S; Kulis M; Segura V; Bergmann A; Esteve A; Merkel A; Raineri E; Agueda L; Blanc J; Richardson D; Clarke L; Datta A; Russiñol N; Queirós AC; Beekman R; Rodríguez-Madoz JR; San José-Enériz E; Fang F; Gutiérrez NC; García-Verdugo JM; Robson MI; Schirmer EC; Guruceaga E; Martens JH; Gut M; Calasanz MJ; Flicek P; Siebert R; Campo E; Miguel JF; Melnick A; Stunnenberg HG; Gut IG; Prosper F; Martín-Subero JI
Genome Res; 2015 Apr; 25(4):478-87. PubMed ID: 25644835
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth.
Tatetsu H; Ueno S; Hata H; Yamada Y; Takeya M; Mitsuya H; Tenen DG; Okuno Y
Cancer Res; 2007 Jun; 67(11):5328-36. PubMed ID: 17545613
[TBL] [Abstract][Full Text] [Related]
14. The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma.
Choudhury SR; Ashby C; Tytarenko R; Bauer M; Wang Y; Deshpande S; Den J; Schinke C; Zangari M; Thanendrarajan S; Davies FE; van Rhee F; Morgan GJ; Walker BA
J Hematol Oncol; 2020 Aug; 13(1):108. PubMed ID: 32762714
[TBL] [Abstract][Full Text] [Related]
15. PU.1 regulates positive regulatory domain I-binding factor 1/Blimp-1 transcription in lymphoma cells.
Desai S; Bolick SC; Maurin M; Wright KL
J Immunol; 2009 Nov; 183(9):5778-87. PubMed ID: 19828640
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation induced epigenetic silencing of DAZAP2, a downstream effector of p38/MAPK pathway, in multiple myeloma cells.
Li J; Hu WX; Luo SQ; Xiong DH; Sun S; Wang YP; Bu XF; Liu J; Hu J
Cell Signal; 2019 Aug; 60():136-145. PubMed ID: 31034872
[TBL] [Abstract][Full Text] [Related]
17. EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.
Alzrigat M; Párraga AA; Agarwal P; Zureigat H; Österborg A; Nahi H; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H
Oncotarget; 2017 Feb; 8(6):10213-10224. PubMed ID: 28052011
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of the human nucleotide excision repair gene, hHR23B, in interleukin-6-responsive multiple myeloma KAS-6/1 cells.
Peng B; Hodge DR; Thomas SB; Cherry JM; Munroe DJ; Pompeia C; Xiao W; Farrar WL
J Biol Chem; 2005 Feb; 280(6):4182-7. PubMed ID: 15550378
[TBL] [Abstract][Full Text] [Related]
19. NonO Is a Novel Co-factor of PRDM1 and Regulates Inflammatory Response in Monocyte Derived-Dendritic Cells.
Lee K; Jang SH; Tian H; Kim SJ
Front Immunol; 2020; 11():1436. PubMed ID: 32765503
[TBL] [Abstract][Full Text] [Related]
20. Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.
Wilop S; van Gemmeren TB; Lentjes MH; van Engeland M; Herman JG; Brümmendorf TH; Jost E; Galm O
Epigenetics; 2011 Aug; 6(8):1047-52. PubMed ID: 21934357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
